What is the best time to evaluate treatment response after radiofrequency ablation of hepatocellular carcinoma using contrast-enhanced sonography?

Oncology

Volumn 72, Issue SUPPL. 1, 2007, Pages 92-97

  Zhou, Pei ^a   Kudo, Masatoshi ^b   Minami, Yasunori ^b   Chung, Hobyung ^b   Inoue, Tatsuo ^b   Fukunaga, Toyokazu ^b   Maekawa, Kiyoshi ^b  

^a WUHAN GENERAL HOSPITAL OF GUANGZHOU COMMAND   (China)

^b KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Gray scale sonography; Hepatic tumor; Radiofrequency ablation; Safety margin; Tumor boundary

Indexed keywords

ADULT; AGED; CANCER DIAGNOSIS; CANCER PATIENT; CANCER TISSUE; CLINICAL ARTICLE; CLINICAL OBSERVATION; CLINICAL TRIAL; CONFERENCE PAPER; CONTRAST ENHANCEMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; GRAY SCALE ECHOGRAPHY; HUMAN; LIVER CELL CARCINOMA; MEDICAL DECISION MAKING; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RADIOFREQUENCY ABLATION; SCORING SYSTEM; SINGLE BLIND PROCEDURE; STATISTICAL SIGNIFICANCE; TREATMENT RESPONSE; VISIBILITY;

AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; CONTRAST MEDIA; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; TIME FACTORS; TREATMENT OUTCOME; ULTRASONOGRAPHY;

EID: 37149041578     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000111713     Document Type: Conference Paper

References (17)

1. Castells A, Bruix J, Bru C, et al: Treatment of small hepatocellular carcinoma in cirrhotic patients: a cohort study comparing surgical resection and percutaneous ethanol injection. Hepatology 1993;18:1121-1126.
2. The Liver Cancer Study Group of Japan: Predictive factors for long term prognosis after partial hepatectomy for patients with hepatocellular carcinoma in Japan. The Liver Cancer Study Group of Japan. Cancer 1994;74:2772-2780.
3. Kudo M, Chung H, Haji S, et al: Validation of a new prognostic staging system for hepatocellular carcinoma, the JIS score as compared with CLIP score. Hepatology 2004;40:1396-1405.
4. Shiina S, Teratani T, Obi S, et al: A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma. Gastroenterology 2005;129:122-130.
5. Lencioni RA, Allgaier HP, Cioni D, et al: Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection. Radiology 2003;228:235-240.
6. Shibata T, Iimuro Y, Yamamoto Y, et al: Small hepatocellular carcinoma: comparison of radio-frequency ablation and percutaneous microwave coagulation therapy. Radiology 2002;223:331-337.
7. Wen YL, Kudo M, Zheng RQ, et al: Radiofrequency ablation of hepatocellular carcinoma: therapeutic response using contrast-enhanced coded phase-inversion harmonic sonography. AJR Am J Roentgenol 2003;181:57-63.
8. Gazelle GS, Goldberg SN, Solbiati L, Livraghi T: Tumor ablation with radio-frequency energy. Radiology 2000;217:633-646.
9. Lim HK: Radiofrequency thermal ablation of hepatocellular carcinoma. Korean J Radiol 2000;1:175-184.
10. Kudo M: Local ablation therapy for hepatocellular carcinoma: current status and future perspective. J Gastroenterol 2004;39:205-214.
11. Solbiati L, Goldberg SN, Ierace T, et al: Hepatic metastases: percutaneous radio-frequency ablation with cooled-tip electrodes. Radiology 1997;205:367-373.
12. Goldberg SN, Gazelle GS, Solbiati L, et al: Ablation of liver tumors using percutaneous RF therapy. AJR Am J Roentgenol 1998;170:1023-1028.
13. Choi D, Lim HK, Kim SH, et al: Hepatocellular carcinoma treated with percutaneous radio-frequency ablation: usefulness of power Doppler US with a microbubble contrast agent in evaluating therapeutic response - preliminary results. Radiology 2000;217:558-563.
14. Sironi S, Livraghi T, Meloni F, De Cobelli F, Ferrero C, Del Maschio A: Small hepatocellular carcinoma treated with percutaneous RF ablation: MR imaging follow-up. AJR Am J Roentgenol 1999;173:1225-1229.
15. Dromain C, de Baere T, Elias D, et al: Hepatic tumors treated with percutaneous radiofrequency ablation: CT and MR imaging follow-up. Radiology 2002;223:255-262.
16. Solbiati L, Goldberg SN, Ierace T, Dellanoce M, Livraghi T, Gazelle GS: Radio-frequency ablation of hepatic metastases: postprocedural assessment with a US microbubble contrast agent - early experience. Radiology 1999;211:643-649.
17. Correas JM, Bridal L, Lesavre A, et al: Ultrasound contrast agents: properties, principles of action, tolerance, and artifacts. Eur Radiol 2001;11:1316-1328.